SEC
|
Hurlburt Elizabeth
|
EVP
|
|
-140K
|
$11.18
|
-$1.57M
|
|
SEC
|
Mistry Erin
|
EVP, Chief Commercial Officer
|
|
+1.5K
|
$9.99
|
+$14.99K
|
|
SEC
|
Todisco Joseph
|
Chief Executive Officer
|
|
+14K
|
$3.74
|
+$50.72K
|
|
SEC
|
DUNTON ALAN W
|
N/A
|
|
+6K
|
$3.38
|
+$20.28K
|
|
SEC
|
Mistry Erin
|
Chief Commercial Officer
|
|
+1K
|
$4.00
|
+$4.00K
|
|
SEC
|
Todisco Joseph
|
Chief Executive Officer
|
|
+10K
|
$3.71
|
+$37.10K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+6K
|
$4.54
|
+$27.24K
|
|
SEC
|
Todisco Joseph
|
Chief Executive Officer
|
|
+20K
|
$3.82
|
+$76.40K
|
|
SEC
|
Todisco Joseph
|
Chief Executive Officer
|
|
+4.7K
|
$3.92
|
+$18.42K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+5K
|
$3.78
|
+$18.90K
|
|
SEC
|
Todisco Joseph
|
Chief Executive Officer
|
|
+10K
|
$3.38
|
+$33.80K
|
|
SEC
|
David Matthew T
|
Interim CEO and CFO
|
|
+2K
|
$4.50
|
+$9.00K
|
|
SEC
|
David Matthew T
|
Interim CEO and CFO
|
|
+1K
|
$5.07
|
+$5.07K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+10K
|
$5.14
|
+$51.40K
|
|
SEC
|
Masson-Hurlburt Elizabeth
|
EVP, Head of Clinical Ops
|
|
-8K
|
$6.92
|
-$55.36K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+15K
|
$6.03
|
+$90.45K
|
|
SEC
|
David Matthew T
|
Chief Financial Officer
|
|
+1.2K
|
$4.07
|
+$4.68K
|
|
SEC
|
Khan Mehmood
|
N/A
|
|
+46K
|
$4.84
|
+$221.43K
|
|
SEC
|
ARMSTRONG JR. JOHN L.
|
Exec VP of Tech Operations
|
|
+28K
|
$4.22
|
+$116.05K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+4.8K
|
$4.14
|
+$20.00K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+15K
|
$4.08
|
+$61.20K
|
|
SEC
|
Mounts Phoebe
|
General Counsel
|
|
+2.5K
|
$4.03
|
+$10.18K
|
|
SEC
|
DUNTON ALAN W
|
N/A
|
|
+5K
|
$3.95
|
+$19.75K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+10K
|
$3.85
|
+$38.50K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+3.5K
|
$2.61
|
+$9.14K
|
|
SEC
|
Mounts Phoebe
|
General Counsel
|
|
+3.3K
|
$3.05
|
+$9.91K
|
|
SEC
|
Mounts Phoebe
|
General Counsel
|
|
+1.4K
|
$7.04
|
+$10.03K
|
|
SEC
|
Khan Mehmood
|
N/A
|
|
+17K
|
$6.58
|
+$111.86K
|
|
SEC
|
Cook Robert W.
|
Chief Financial Officer
|
|
+1K
|
$6.88
|
+$6.88K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+5K
|
$6.81
|
+$34.05K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
+5K
|
$6.75
|
+$33.75K
|
|
SEC
|
Cook Robert W.
|
Chief Financial Officer
|
|
+2K
|
$8.18
|
+$16.36K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+6.1K
|
$8.19
|
+$50.34K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+6K
|
$8.06
|
+$48.36K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+11K
|
$6.74
|
+$75.11K
|
|
SEC
|
Cook Robert W.
|
Chief Financial Officer
|
|
+100
|
$9.35
|
+$935.00
|
|
SEC
|
ARMSTRONG JR. JOHN L.
|
Exec VP of Tech Operations
|
|
+5K
|
$7.73
|
+$38.65K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+2.5K
|
$7.55
|
+$18.88K
|
|
SEC
|
ARMSTRONG JR. JOHN L.
|
Exec VP of Tech Operations
|
|
+15K
|
$1.69
|
+$25.35K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+20K
|
$1.65
|
+$33.00K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+42K
|
$1.67
|
+$70.14K
|
|
SEC
|
Khan Mehmood
|
N/A
|
|
+100K
|
$1.24
|
+$124.00K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
+20K
|
$1.18
|
+$23.60K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+50K
|
$1.47
|
+$73.50K
|
|
SEC
|
Masson Elizabeth
|
EVP, Head of Clinical Ops.
|
|
+40K
|
$0.29
|
+$11.60K
|
|
SEC
|
ARMSTRONG JR. JOHN L.
|
Exec VP of Tech Operations
|
|
+250K
|
$1.45
|
+$362.50K
|
|
SEC
|
Cook Robert W.
|
Chief Financial Officer
|
|
+25K
|
$1.17
|
+$29.25K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+25K
|
$1.22
|
+$30.50K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+50K
|
$1.30
|
+$65.00K
|
|
SEC
|
Gelbfish Gary A.
|
N/A
|
|
+531K
|
$1.43
|
+$759.69K
|
|
SEC
|
ARMSTRONG JR. JOHN L.
|
Exec VP of Tech Operations
|
|
+21K
|
$0.48
|
+$10.00K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+104K
|
$0.48
|
+$50.00K
|
|
SEC
|
Cook Robert W.
|
Chief Financial Officer
|
|
+52K
|
$0.48
|
+$25.00K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+52K
|
$0.48
|
+$25.00K
|
|
SEC
|
Gelbfish Gary A.
|
N/A
|
|
+52K
|
$0.48
|
+$25.00K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+104K
|
$0.48
|
+$50.00K
|
|
SEC
|
Khan Mehmood
|
N/A
|
|
+52K
|
$0.48
|
+$25.00K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
+135K
|
$0.48
|
+$65.00K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+36K
|
$0.42
|
+$15.21K
|
|
SEC
|
Khan Mehmood
|
N/A
|
|
+400K
|
$0.39
|
+$156.00K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+80K
|
$0.40
|
+$32.00K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+50K
|
$0.35
|
+$17.50K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+7.6K
|
$0.42
|
+$3.17K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+75K
|
$0.48
|
+$36.00K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+50K
|
$0.48
|
+$24.00K
|
|
SEC
|
Cook Robert W.
|
Chief Financial Officer
|
|
+50K
|
$0.50
|
+$25.00K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+21K
|
$0.48
|
+$10.19K
|
|
SEC
|
GEORGE MICHAEL W
|
N/A
|
|
+10K
|
$0.50
|
+$5.00K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+30K
|
$0.49
|
+$14.70K
|
|
SEC
|
Markvicka Taunia
|
N/A
|
|
+15K
|
$0.51
|
+$7.40K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+4.8K
|
$0.66
|
+$3.17K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+2K
|
$1.66
|
+$3.24K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+1.5K
|
$2.10
|
+$3.23K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+1.8K
|
$1.79
|
+$3.19K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+2K
|
$1.58
|
+$3.14K
|
|
SEC
|
Baluch Khoso
|
Chief Executive Officer
|
|
+10K
|
$1.77
|
+$17.70K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+1.8K
|
$1.80
|
+$3.24K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+1.5K
|
$2.15
|
+$3.17K
|
|
SEC
|
Pfaffle Antony
|
Chief Scientific Officer
|
|
-20K
|
$2.23
|
-$44.60K
|
|
SEC
|
Markvicka Taunia
|
N/A
|
|
+19K
|
$1.65
|
+$30.69K
|
|
SEC
|
Kaplan Myron
|
N/A
|
|
+20K
|
$1.72
|
+$34.40K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+13K
|
$1.73
|
+$21.63K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-30K
|
$2.14
|
-$63.47K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-4.9K
|
$2.21
|
-$10.83K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-5.4K
|
$2.27
|
-$12.36K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-10K
|
$2.38
|
-$23.80K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+3.7K
|
$2.67
|
+$9.98K
|
|
SEC
|
Duffy Matthew
|
N/A
|
|
-46K
|
$2.73
|
-$125.87K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
-50K
|
$2.88
|
-$144.00K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+8.6K
|
$2.90
|
+$24.94K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-13K
|
$2.73
|
-$34.67K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
-30K
|
$2.93
|
-$87.90K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-15K
|
$2.89
|
-$43.35K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-12K
|
$2.82
|
-$34.69K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-60K
|
$2.68
|
-$160.80K
|
|
SEC
|
Dillione Janet
|
N/A
|
|
+15K
|
$2.66
|
+$39.90K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+1.6K
|
$3.88
|
+$6.25K
|
|
SEC
|
Markvicka Taunia
|
N/A
|
|
+4K
|
$4.81
|
+$19.24K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+1.2K
|
$5.02
|
+$6.25K
|
|
SEC
|
Duffy Matthew
|
N/A
|
|
-30K
|
$6.48
|
-$194.40K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
-39K
|
$6.53
|
-$255.14K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-30K
|
$6.37
|
-$191.10K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+1K
|
$6.09
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+979
|
$6.38
|
+$6.25K
|
|
SEC
|
Pfaffle Antony
|
Interim Chief Medical Officer
|
|
-17K
|
$6.49
|
-$108.55K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+730
|
$8.55
|
+$6.24K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+1.2K
|
$5.16
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+1.9K
|
$3.27
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+2K
|
$3.10
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+3.3K
|
$1.91
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+4.7K
|
$1.32
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+4.5K
|
$1.40
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+4.1K
|
$1.52
|
+$6.25K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+11K
|
$1.52
|
+$16.85K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+3.4K
|
$1.82
|
+$6.25K
|
|
SEC
|
TELLEZ CORA M
|
N/A
|
|
+2.1K
|
$1.55
|
+$3.26K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+4.1K
|
$1.54
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+3.3K
|
$1.88
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+3.7K
|
$1.71
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+3.1K
|
$2.00
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+3.1K
|
$1.99
|
+$6.25K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+6.3K
|
$2.00
|
+$12.50K
|
|
SEC
|
MILBY RANDY
|
Chief Executive Officer
|
|
+2.7K
|
$1.83
|
+$5.00K
|
|
SEC
|
Lefkowitz Steven W
|
Interim Chief Financial Ofcr
|
|
+18K
|
$0.78
|
+$14.04K
|
|
SEC
|
PHARMABIO DEVELOPMENT INC
|
N/A
|
|
-11K
|
$0.45
|
-$4.95K
|
|
SEC
|
Gelbfish Gary A.
|
N/A
|
|
+23K
|
$0.33
|
+$7.69K
|
|
SEC
|
Lefkowitz Steven W
|
N/A
|
|
+15K
|
$0.31
|
+$4.65K
|
|
SEC
|
Lefkowitz James
|
N/A
|
|
+1.2K
|
$0.31
|
+$372.00
|
|
SEC
|
Pfaffle Antony
|
N/A
|
|
+2K
|
$0.32
|
+$640.00
|
|
SEC
|
LENZ BRIAN
|
CFO, TREASURER & SECRETARY
|
|
+14K
|
$0.34
|
+$4.76K
|
|
SEC
|
HOFER TIMOTHY M
|
N/A
|
|
+1K
|
$0.33
|
+$330.00
|
|
SEC
|
Houser Mark T.
|
Chief Medical Officer
|
|
+5K
|
$1.30
|
+$6.50K
|
|
SEC
|
Houghton John C.
|
President and CEO
|
|
+1K
|
$1.62
|
+$1.62K
|
|
SEC
|
Houser Mark T.
|
Chief Medical Officer
|
|
+5K
|
$1.50
|
+$7.50K
|
|
SEC
|
LENZ BRIAN
|
Chief Financial Officer
|
|
+1K
|
$1.54
|
+$1.54K
|
|